Medimaps Group

medical devices

About

Medimaps Group is a Swiss medical technology company that specializes in AI-driven software for bone health management. The company focuses on assessing bone microarchitecture to improve fracture risk prediction and support osteoporosis treatment decisions. Founded by medical practitioners and clinical researchers, Medimaps has a global presence with offices in Geneva, the United States, and France, employing around 50 people. The flagship product is the Trabecular Bone Score (TBS) technology, an AI-powered software solution that integrates with DXA machines. This software enhances the evaluation of bone quality by analyzing bone microarchitecture, which is essential for predicting fracture risk in patients with osteoporosis and other related conditions. Medimaps also provides professional services to pharmaceutical and medical device companies, aiding in the development of new treatments for osteoporosis and orthopedic issues. The company aims to simplify complex clinical needs into routine solutions that enhance patient care and quality of life.

Technologies

Salesforce Outlook Backbone JS Library AI

Keywords

bone texture analysis osteoporosis trabecular bone score bone microarchitecture dxa radiology bone densitometry ai medical equipment manufacturing clinical trial support bone health monitoring healthcare equipment & supplies deep-tech innovations telemedicine bone health diagnostics dxa integration medical device regulation patient-centric technology opportunistic fracture risk assessment reimbursement codes medical software certification clinical decision support consulting non-invasive diagnostics healthcare industry leader osteoporosis treatment monitoring dxa scan analysis medical devices ai medical diagnostics tbs osteo

Location

36 Chemin du Champ-des-Filles, Plan-les-Ouates, Geneva, Switzerland, 1228

Related Companies

Companies in the same industry